Dr Jeremy Rees
Dr Jeremy Rees qualified in 1988 from University College and Middlesex Medical School with distinctions in Medicine, Surgery and Therapeutics. After postgraduate training, including a spell at Memorial Sloan Kettering Hospital, New York, in 1999 he was appointed as Honorary Senior Lecturer in Neuro-oncology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery. He specializes in the management of low-grade brain tumours and neurological complications of cancer.
Having been the Clinical Lead for the Brain Tumour Unit at UCLH and the Pathway Director for Brain Cancer at London Cancer, he is now a member of the NICE Guidelines Committee for writing national guidelines on the treatment of brain tumours. He leads a research team investigating the role of multimodality imaging in the management of Low Grade Gliomas, has edited a textbook on Neuro-oncology, written numerous peer-reviewed research papers and chapters on Neuro-oncology and lectures extensively to different professional groups.
Research & clinical interests
Low –Grade Gliomas
Neurological complications of cancer treatments
Paraneoplastic Neurological Syndromes
Research into brain tumour imaging
NICE Guidelines Committee
Association of British Neurologist Advisory Group for Neuro-oncology
Advanced MRI techniques in the monitoring of treatment of gliomas. Hyare H, Thust S, Rees J. Current Treatment Options in Neurology. 2017;19:11
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Baumert B, Hegi MR, van den Bent M et al. Lancet Oncology 2016;17: 1522-1532
Acute demyelination following radiotherapy for glioma: a cautionary tale. Milic M, Rees JH. Pract Neurol. 2017 ; 17: 35-38
Diagnostic delay and survival in high grade gliomas – evidence of the “waiting time paradox”? Aggarwal A, Herz N, Campbell P, Arkush L, Short S, Rees J. Br J Neurosurg 2015 ; 4: 1-4
Predicting outcomes of vocational rehabilitation in patients with brain tumours. Rusbridge SL, Walmsley NC, Griffiths SB, Wilford PA, Rees JH. Psychooncology. 2013;22:1907-11Back to council